| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
33,827 |
32,646 |
$4.33M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,148 |
6,630 |
$2.42M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,749 |
9,685 |
$305K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,306 |
2,228 |
$300K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,006 |
2,917 |
$186K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,044 |
3,876 |
$166K |
| 71045 |
Radiologic examination, chest; single view |
3,888 |
3,682 |
$95K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,388 |
3,262 |
$67K |
| 87430 |
|
2,453 |
2,378 |
$49K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,135 |
1,053 |
$47K |
| 80053 |
Comprehensive metabolic panel |
3,868 |
3,539 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
661 |
617 |
$39K |
| 87070 |
|
3,107 |
3,021 |
$39K |
| 85027 |
|
5,997 |
5,395 |
$27K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
757 |
691 |
$20K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,437 |
1,305 |
$12K |
| 81001 |
|
3,423 |
3,215 |
$10K |
| 76801 |
|
61 |
52 |
$6K |
| 81025 |
|
762 |
718 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
100 |
99 |
$5K |
| 84484 |
|
574 |
432 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
41 |
40 |
$4K |
| 83690 |
|
1,067 |
989 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
768 |
593 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,221 |
1,089 |
$2K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12 |
12 |
$2K |
| 87420 |
|
131 |
124 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18 |
15 |
$2K |
| 84702 |
|
135 |
113 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
307 |
261 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
15 |
12 |
$1K |
| 87807 |
|
58 |
50 |
$920.55 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
115 |
90 |
$777.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
613 |
355 |
$720.00 |
| 81003 |
|
116 |
107 |
$710.10 |
| 70450 |
Computed tomography, head or brain; without contrast material |
13 |
13 |
$652.21 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
92 |
84 |
$565.01 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
26 |
26 |
$294.92 |
| 83880 |
|
45 |
38 |
$201.95 |
| 86901 |
|
76 |
70 |
$150.60 |
| 85610 |
|
116 |
107 |
$98.02 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
59 |
51 |
$9.39 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
26 |
12 |
$8.72 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
14 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
32 |
28 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
84 |
80 |
$0.00 |